Referred to the House Committee on Energy and Commerce.
This bill amends the Public Health Service Act to reauthorize and update existing federal programs concerning tick‑borne and other vector‑borne diseases.
It amends Section 317U to add language referencing the Tick‑Borne Disease Working Group and other appropriate individuals, adds an explicit goal of increasing capacity to identify, report, prevent, and respond to such diseases, and extends the program authorization period from 2021–2025 to 2026–2030.
It also amends Section 2822(c) to extend enhanced support for state and local health departments from 2021–2025 to 2026–2030.
Content is narrowly focused, technical, and addresses public health infrastructure — factors that historically favor enactment absent strong controversy. The bill primarily extends and clarifies existing authorities rather than creating contentious new policy, making it relatively likely to clear committee and floor consideration. Final enactment still depends on appropriations and legislative scheduling.
Relative to its intended legislative type, this bill is a narrowly focused statutory housekeeping measure that precisely amends cited provisions to extend authorization periods and make minor textual clarifications.
Scope of federal role and safeguards: conservatives worry about mission creep and unfunded spending; liberals want robust funding and expansion to address equity and climate drivers.
Scope of federal role and safeguards: conservatives worry about mission creep and unfunded spending; liberals want robust funding and expansion to address equity and climate drivers.
A liberal/left‑leaning observer would likely view this bill positively as a modest but necessary step to sustain and slightly strengthen federal efforts against tick‑borne and other vector‑borne diseases.
They would welcome the explicit inclusion of the Tick‑Borne Disease Working Group and language about increasing capacity to identify, report, prevent, and respond.
They would also likely press for robust appropriations, attention to environmental and climate drivers of vector spread, and equity in how resources are distributed to underserved communities.
A centrist/moderate observer would view the bill as a pragmatic, narrowly targeted reauthorization of public health activity that is reasonable and mostly noncontroversial.
They would appreciate the continuity for surveillance and support to health departments but would want clarity on costs, oversight, and measurable outcomes.
Overall they would be inclined to support reauthorization while pressing for accountability and cost transparency.
A mainstream conservative observer would likely be cautiously supportive of a narrowly targeted public health reauthorization focused on surveillance and assistance to state/local health departments, but would be attentive to fiscal and federalism concerns.
They would prefer limited, well‑defined federal roles, oversight of spending, and assurances that this does not create broad new mandates or open‑ended entitlement spending.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrowly focused, technical, and addresses public health infrastructure — factors that historically favor enactment absent strong controversy. The bill primarily extends and clarifies existing authorities rather than creating contentious new policy, making it relatively likely to clear committee and floor consideration. Final enactment still depends on appropriations and legislative scheduling.
The bill has not accumulated any surfaced votes yet.
Scope of federal role and safeguards: conservatives worry about mission creep and unfunded spending; liberals want robust funding and expan…
Content is narrowly focused, technical, and addresses public health infrastructure — factors that historically favor enactment absent stron…
Relative to its intended legislative type, this bill is a narrowly focused statutory housekeeping measure that precisely amends cited provisions to extend authorization periods and make minor textual clarifications.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.